Integration of the Duke Activity Status Index into preoperative risk evaluation: a multicentre prospective cohort study.


Journal

British journal of anaesthesia
ISSN: 1471-6771
Titre abrégé: Br J Anaesth
Pays: England
ID NLM: 0372541

Informations de publication

Date de publication:
03 2020
Historique:
received: 11 09 2019
revised: 28 10 2019
accepted: 23 11 2019
pubmed: 23 12 2019
medline: 29 2 2020
entrez: 23 12 2019
Statut: ppublish

Résumé

The Duke Activity Status Index (DASI) questionnaire might help incorporate self-reported functional capacity into preoperative risk assessment. Nonetheless, prognostically important thresholds in DASI scores remain unclear. We conducted a nested cohort analysis of the Measurement of Exercise Tolerance before Surgery (METS) study to characterise the association of preoperative DASI scores with postoperative death or complications. The analysis included 1546 participants (≥40 yr of age) at an elevated cardiac risk who had inpatient noncardiac surgery. The primary outcome was 30-day death or myocardial injury. The secondary outcomes were 30-day death or myocardial infarction, in-hospital moderate-to-severe complications, and 1 yr death or new disability. Multivariable logistic regression modelling was used to characterise the adjusted association of preoperative DASI scores with outcomes. The DASI score had non-linear associations with outcomes. Self-reported functional capacity better than a DASI score of 34 was associated with reduced odds of 30-day death or myocardial injury (odds ratio: 0.97 per 1 point increase above 34; 95% confidence interval [CI]: 0.96-0.99) and 1 yr death or new disability (odds ratio: 0.96 per 1 point increase above 34; 95% CI: 0.92-0.99). Self-reported functional capacity worse than a DASI score of 34 was associated with increased odds of 30-day death or myocardial infarction (odds ratio: 1.05 per 1 point decrease below 34; 95% CI: 1.00-1.09), and moderate-to-severe complications (odds ratio: 1.03 per 1 point decrease below 34; 95% CI: 1.01-1.05). A DASI score of 34 represents a threshold for identifying patients at risk for myocardial injury, myocardial infarction, moderate-to-severe complications, and new disability.

Sections du résumé

BACKGROUND
The Duke Activity Status Index (DASI) questionnaire might help incorporate self-reported functional capacity into preoperative risk assessment. Nonetheless, prognostically important thresholds in DASI scores remain unclear. We conducted a nested cohort analysis of the Measurement of Exercise Tolerance before Surgery (METS) study to characterise the association of preoperative DASI scores with postoperative death or complications.
METHODS
The analysis included 1546 participants (≥40 yr of age) at an elevated cardiac risk who had inpatient noncardiac surgery. The primary outcome was 30-day death or myocardial injury. The secondary outcomes were 30-day death or myocardial infarction, in-hospital moderate-to-severe complications, and 1 yr death or new disability. Multivariable logistic regression modelling was used to characterise the adjusted association of preoperative DASI scores with outcomes.
RESULTS
The DASI score had non-linear associations with outcomes. Self-reported functional capacity better than a DASI score of 34 was associated with reduced odds of 30-day death or myocardial injury (odds ratio: 0.97 per 1 point increase above 34; 95% confidence interval [CI]: 0.96-0.99) and 1 yr death or new disability (odds ratio: 0.96 per 1 point increase above 34; 95% CI: 0.92-0.99). Self-reported functional capacity worse than a DASI score of 34 was associated with increased odds of 30-day death or myocardial infarction (odds ratio: 1.05 per 1 point decrease below 34; 95% CI: 1.00-1.09), and moderate-to-severe complications (odds ratio: 1.03 per 1 point decrease below 34; 95% CI: 1.01-1.05).
CONCLUSIONS
A DASI score of 34 represents a threshold for identifying patients at risk for myocardial injury, myocardial infarction, moderate-to-severe complications, and new disability.

Identifiants

pubmed: 31864719
pii: S0007-0912(19)30929-8
doi: 10.1016/j.bja.2019.11.025
pii:
doi:

Substances chimiques

Biomarkers 0
Peptide Fragments 0
pro-brain natriuretic peptide (1-76) 0
Natriuretic Peptide, Brain 114471-18-0

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

261-270

Subventions

Organisme : Medical Research Council
ID : MR/M017974/1
Pays : United Kingdom
Organisme : British Heart Foundation
Pays : United Kingdom

Investigateurs

B H Cuthbertson (BH)
D N Wijeysundera (DN)
R M Pearse (RM)
P S Myles (PS)
T E F Abbott (TEF)
M A Shulman (MA)
B H Cuthbertson (BH)
D N Wijeysundera (DN)
E Torres (E)
A Ambosta (A)
M Melo (M)
M Mamdani (M)
K E Thorpe (KE)
R M Pearse (RM)
T E F Abbott (TEF)
P S Myles (PS)
M A Shulman (MA)
S Wallace (S)
C Farrington (C)
B L Croal (BL)
M P W Grocott (MPW)
J T Granton (JT)
P Oh (P)
B Thompson (B)
D Levett (D)
G Hillis (G)
W S Beattie (WS)
H C Wijeysundera (HC)
B H Cuthbertson (BH)
D N Wijeysundera (DN)
R M Pearse (RM)
M A Shulman (MA)
T E F Abbott (TEF)
E Torres (E)
A Ambosta (A)
B L Croal (BL)
J T Granton (JT)
K E Thorpe (KE)
M P W Grocott (MPW)
C Farrington (C)
S Wallace (S)
P S Myles (PS)

Informations de copyright

Copyright © 2019 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Auteurs

Duminda N Wijeysundera (DN)

Department of Anesthesia, St Michael's Hospital, Toronto, ON, Canada; Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, ON, Canada; Department of Anesthesiology and Pain Medicine, University of Toronto, Toronto, ON, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada; Department of Anesthesia and Pain Management, University Health Network, Toronto, ON, Canada. Electronic address: d.wijeysundera@utoronto.ca.

W Scott Beattie (WS)

Department of Anesthesiology and Pain Medicine, University of Toronto, Toronto, ON, Canada; Department of Anesthesia and Pain Management, University Health Network, Toronto, ON, Canada.

Graham S Hillis (GS)

Department of Cardiology, Royal Perth Hospital, Perth, Western Australia, Australia; Faculty of Health and Medical Sciences, University of Western Australia, Perth, Western Australia, Australia.

Tom E F Abbott (TEF)

The William Harvey Research Institute, Queen Mary University of London, London, UK; Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

Mark A Shulman (MA)

Department of Anaesthesiology and Perioperative Medicine, The Alfred Hospital and Monash University, Melbourne, VIC, Australia; Department of Anaesthesiology and Perioperative Medicine, Monash University, Melbourne, VIC, Australia.

Gareth L Ackland (GL)

The William Harvey Research Institute, Queen Mary University of London, London, UK; Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

C David Mazer (CD)

Department of Anesthesia, St Michael's Hospital, Toronto, ON, Canada; Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, ON, Canada; Department of Anesthesiology and Pain Medicine, University of Toronto, Toronto, ON, Canada.

Paul S Myles (PS)

Department of Anaesthesiology and Perioperative Medicine, The Alfred Hospital and Monash University, Melbourne, VIC, Australia; Department of Anaesthesiology and Perioperative Medicine, Monash University, Melbourne, VIC, Australia.

Rupert M Pearse (RM)

Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

Brian H Cuthbertson (BH)

Department of Anesthesiology and Pain Medicine, University of Toronto, Toronto, ON, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada; Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.

P S Myles (PS)

Alfred Hospital, Australia.

M A Shulman (MA)

Alfred Hospital, Australia.

S Wallace (S)

Alfred Hospital, Australia.

C Farrington (C)

Alfred Hospital, Australia.

B Thompson (B)

Alfred Hospital, Australia.

M Ellis (M)

Alfred Hospital, Australia.

B Borg (B)

Alfred Hospital, Australia.

R K Kerridge (RK)

John Hunter Hospital, Australia.

J Douglas (J)

John Hunter Hospital, Australia.

J Brannan (J)

John Hunter Hospital, Australia.

J Pretto (J)

John Hunter Hospital, Australia.

M G Godsall (MG)

Nambour General Hospital, Australia.

N Beauchamp (N)

Nambour General Hospital, Australia.

S Allen (S)

Nambour General Hospital, Australia.

A Kennedy (A)

Nambour General Hospital, Australia.

E Wright (E)

Nambour General Hospital, Australia.

J Malherbe (J)

Nambour General Hospital, Australia.

H Ismail (H)

Peter McCallum Cancer Centre, Australia.

B Riedel (B)

Peter McCallum Cancer Centre, Australia.

A Melville (A)

Peter McCallum Cancer Centre, Australia.

H Sivakumar (H)

Peter McCallum Cancer Centre, Australia.

A Murmane (A)

Peter McCallum Cancer Centre, Australia.

K Kenchington (K)

Peter McCallum Cancer Centre, Australia.

Y Kirabiyik (Y)

Peter McCallum Cancer Centre, Australia.

U Gurunathan (U)

Prince Charles Hospital, Australia.

C Stonell (C)

Prince Charles Hospital, Australia.

K Brunello (K)

Prince Charles Hospital, Australia.

K Steele (K)

Prince Charles Hospital, Australia.

O Tronstad (O)

Prince Charles Hospital, Australia.

P Masel (P)

Prince Charles Hospital, Australia.

A Dent (A)

Prince Charles Hospital, Australia.

E Smith (E)

Prince Charles Hospital, Australia.

A Bodger (A)

Prince Charles Hospital, Australia.

M Abolfathi (M)

Prince Charles Hospital, Australia.

P Sivalingam (P)

Princess Alexandra Hospital, Australia.

A Hall (A)

Princess Alexandra Hospital, Australia.

T W Painter (TW)

Royal Adelaide Hospital, Australia.

S Macklin (S)

Royal Adelaide Hospital, Australia.

A Elliott (A)

Royal Adelaide Hospital, Australia.

A M Carrera (AM)

Royal Adelaide Hospital, Australia.

N C S Terblanche (NCS)

Royal Hobart Hospital, Australia.

S Pitt (S)

Royal Hobart Hospital, Australia.

J Samuels (J)

Royal Hobart Hospital, Australia.

C Wilde (C)

Royal Hobart Hospital, Australia.

K Leslie (K)

Royal Melbourne Hospital, Australia.

A MacCormick (A)

Royal Melbourne Hospital, Australia.

D Bramley (D)

Western Health, Australia.

A M Southcott (AM)

Western Health, Australia.

J Grant (J)

Western Health, Australia.

H Taylor (H)

Western Health, Australia.

S Bates (S)

Western Health, Australia.

M Towns (M)

Western Health, Australia.

A Tippett (A)

Western Health, Australia.

F Marshall (F)

Western Health, Australia.

C D Mazer (CD)

St Michael's Hospital, Canada.

J Kunasingam (J)

St Michael's Hospital, Canada.

A Yagnik (A)

St Michael's Hospital, Canada.

C Crescini (C)

St Michael's Hospital, Canada.

S Yagnik (S)

St Michael's Hospital, Canada.

C J L McCartney (CJL)

Sunnybrook Health Sciences Centre, Canada.

S Choi (S)

Sunnybrook Health Sciences Centre, Canada.

P Somascanthan (P)

Sunnybrook Health Sciences Centre, Canada.

K Flores (K)

Sunnybrook Health Sciences Centre, Canada.

D N Wijeysundera (DN)

Toronto General Hospital, Canada.

W S Beattie (WS)

Toronto General Hospital, Canada.

K Karkouti (K)

Toronto General Hospital, Canada.

H A Clarke (HA)

Toronto General Hospital, Canada.

A Jerath (A)

Toronto General Hospital, Canada.

S A McCluskey (SA)

Toronto General Hospital, Canada.

M Wasowicz (M)

Toronto General Hospital, Canada.

J T Granton (JT)

Toronto General Hospital, Canada.

L Day (L)

Toronto General Hospital, Canada.

J Pazmino-Canizares (J)

Toronto General Hospital, Canada.

P Oh (P)

Toronto Rehabilitation Institute - Rumsey Centre, Canada.

R Belliard (R)

Toronto Rehabilitation Institute - Rumsey Centre, Canada.

L Lee (L)

Toronto Rehabilitation Institute - Rumsey Centre, Canada.

K Dobson (K)

Toronto Rehabilitation Institute - Rumsey Centre, Canada.

V Chan (V)

Toronto Western Hospital, Canada.

R Brull (R)

Toronto Western Hospital, Canada.

N Ami (N)

Toronto Western Hospital, Canada.

M Stanbrook (M)

Toronto Western Hospital, Canada.

K Hagen (K)

Auckland City Hospital, New Zealand.

D Campbell (D)

Auckland City Hospital, New Zealand.

T Short (T)

Auckland City Hospital, New Zealand.

J Van Der Westhuizen (J)

Auckland City Hospital, New Zealand.

K Higgie (K)

Auckland City Hospital, New Zealand.

H Lindsay (H)

Auckland City Hospital, New Zealand.

R Jang (R)

Auckland City Hospital, New Zealand.

C Wong (C)

Auckland City Hospital, New Zealand.

D Mcallister (D)

Auckland City Hospital, New Zealand.

M Ali (M)

Auckland City Hospital, New Zealand.

J Kumar (J)

Auckland City Hospital, New Zealand.

E Waymouth (E)

Auckland City Hospital, New Zealand.

C Kim (C)

Auckland City Hospital, New Zealand.

J Dimech (J)

Middlemore Hospital, New Zealand.

M Lorimer (M)

Middlemore Hospital, New Zealand.

J Tai (J)

Middlemore Hospital, New Zealand.

R Miller (R)

Middlemore Hospital, New Zealand.

R Sara (R)

Middlemore Hospital, New Zealand.

A Collingwood (A)

Middlemore Hospital, New Zealand.

S Olliff (S)

Middlemore Hospital, New Zealand.

S Gabriel (S)

Middlemore Hospital, New Zealand.

H Houston (H)

Middlemore Hospital, New Zealand.

P Dalley (P)

Wellington Hospital, New Zealand.

S Hurford (S)

Wellington Hospital, New Zealand.

A Hunt (A)

Wellington Hospital, New Zealand.

L Andrews (L)

Wellington Hospital, New Zealand.

L Navarra (L)

Wellington Hospital, New Zealand.

A Jason-Smith (A)

Wellington Hospital, New Zealand.

H Thompson (H)

Wellington Hospital, New Zealand.

N McMillan (N)

Wellington Hospital, New Zealand.

G Back (G)

Wellington Hospital, New Zealand.

B L Croal (BL)

Aberdeen Royal Infirmary, United Kingdom.

M Lum (M)

Aberdeen Royal Infirmary, United Kingdom.

D Martin (D)

Royal Free Hospital, United Kingdom.

S James (S)

Royal Free Hospital, United Kingdom.

H Filipe (H)

Royal Free Hospital, United Kingdom.

M Pinto (M)

Royal Free Hospital, United Kingdom.

S Kynaston (S)

Royal Free Hospital, United Kingdom.

R M Pearse (RM)

Royal London Hospital, United Kingdom.

T E F Abbott (TEF)

Royal London Hospital, United Kingdom.

M Phull (M)

Royal London Hospital, United Kingdom.

C Beilstein (C)

Royal London Hospital, United Kingdom.

P Bodger (P)

Royal London Hospital, United Kingdom.

K Everingham (K)

Royal London Hospital, United Kingdom.

Y Hu (Y)

Royal London Hospital, United Kingdom.

E Niebrzegowska (E)

Royal London Hospital, United Kingdom.

C Corriea (C)

Royal London Hospital, United Kingdom.

T Creary (T)

Royal London Hospital, United Kingdom.

M Januszewska (M)

Royal London Hospital, United Kingdom.

T Ahmad (T)

Royal London Hospital, United Kingdom.

J Whalley (J)

Royal London Hospital, United Kingdom.

R Haslop (R)

Royal London Hospital, United Kingdom.

J McNeil (J)

Royal London Hospital, United Kingdom.

A Brown (A)

Royal London Hospital, United Kingdom.

N MacDonald (N)

Royal London Hospital, United Kingdom.

M Pakats (M)

Royal London Hospital, United Kingdom.

K Greaves (K)

Royal London Hospital, United Kingdom.

S Jhanji (S)

Royal Marsden Hospital, United Kingdom.

R Raobaikady (R)

Royal Marsden Hospital, United Kingdom.

E Black (E)

Royal Marsden Hospital, United Kingdom.

M Rooms (M)

Royal Marsden Hospital, United Kingdom.

H Lawrence (H)

Royal Marsden Hospital, United Kingdom.

M Koutra (M)

Royal Marsden Hospital, United Kingdom.

K Pirie (K)

Royal Marsden Hospital, United Kingdom.

M Gertsman (M)

Royal Marsden Hospital, United Kingdom.

S Jack (S)

Southampton General Hospital, United Kingdom.

M Celinski (M)

Southampton General Hospital, United Kingdom.

D Levett (D)

Southampton General Hospital, United Kingdom.

M Edwards (M)

Southampton General Hospital, United Kingdom.

K Salmon (K)

Southampton General Hospital, United Kingdom.

C Bolger (C)

Southampton General Hospital, United Kingdom.

L Loughney (L)

Southampton General Hospital, United Kingdom.

L Seaward (L)

Southampton General Hospital, United Kingdom.

H Collins (H)

Southampton General Hospital, United Kingdom.

B Tyrell (B)

Southampton General Hospital, United Kingdom.

N Tantony (N)

Southampton General Hospital, United Kingdom.

K Golder (K)

Southampton General Hospital, United Kingdom.

G L Ackland (GL)

University College London Hospital, United Kingdom.

R C M Stephens (RCM)

University College London Hospital, United Kingdom.

L Gallego-Paredes (L)

University College London Hospital, United Kingdom.

A Reyes (A)

University College London Hospital, United Kingdom.

A Gutierrez Del Arroyo (A)

University College London Hospital, United Kingdom.

A Raj (A)

Whipps Cross Hospital, United Kingdom.

R Lifford (R)

Whipps Cross Hospital, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH